PARNAX LAB LTD. - 506128 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakash Shah & PACs PARNAX LAB LTD. - 506128 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pragna Prakash Shah & PACs PARNAX LAB LTD. - 506128 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ila Baiju Shah & PACs PARNAX LAB LTD. - 506128 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Baiju Mahasukhlal & PACs PARNAX LAB LTD. - 506128 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ami Mihir Shah & PACs PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Conversion of Securities
Allotment of 16,70,750 Equity Shares upon conversion of Warrants into equivalent number of Equity shares and Compliance of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 PARNAX LAB LTD. - 506128 - Closure of Trading Window
Dear Sir/Madam, Pursuant to BSE Circulars dated 2nd April, 2019 vide Ref No: LIST/COMP/01/2019-20 please note that the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons with effect from 01st July, 2022 for the purpose of consideration of Unaudited Financial result for the quarter and Three Months ended 30th June, 2022. The Trading Window shall open 48 hours after the Unaudited Financial Result for the quarter and Three Months ended 30th June, 2022 becomes generally available to the public. The above is for your information and record. Kindly take the same on your record and oblige. PARNAX LAB LTD. - 506128 - Reg. 32 Statement Of Utilisation Of Funds Raised
Kindly find enclosed herewith the Statement of deviations in the format as pursuant to the Annexure A of the SEBI Circular dated Dec 24, 2019, pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. (A statement is attached herewith as Annexure-II). PARNAX LAB LTD. - 506128 - Results-Audited Financial Results For The Quarter And Year Ended March 31, 2022.
Kindly find enclosed herewith the following: 1. A Copy of Standalone & Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March, 2022, along with Auditors Report thereon, pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. 2. Declaration pursuant to Regulation 33(3)(d) as amended by the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. (A declaration is attached herewith as Annexure-I). 3. Statement of deviations in the format as pursuant to the Annexure A of the SEBI Circular dated Dec 24, 2019, pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. (A statement is attached herewith as Annexure-II). Kindly take on your record and acknowledge receipt of the same.